7-fold increase in use of GLP-1 weight loss drugs among teens, young adults
Research finds a sharp increase in use of weightloss drugs such as Ozempic and Wegovy among teens and young adults
Drugs
Health
Pharma
Drugs
Health
Pharma
Novo Nordisk unveils new drug to fight obesity, says 13% effective
HQ Team March 11, 2024: Danish drugmaker Novo Nordisk’s oral medicine, amycretin, for obesity can cause up to 13% weight loss, the company.
Drugs
Health
Pharma
Novo Nordisk says Ozempic reduces kidney disease progression
HQ Team March 6, 2024: Novo Nordisk’s diabetes drug Ozempic delayed the progression of kidney disease and cardiovascular and kidney deaths in 24%.
Drugs
Health
Pharma
Novo Nordisk diabetes drug meets trial goals against insulin glargine
HQ Team January 9, 2023: Denmark’s Novo Nordisk declared its late-stage experimental once-weekly diabetes drug IcoSema achieved its primary endpoint of proving “non-inferiority” in.
Drugs
Health
Pharma
Eli Lilly’s LillyDirect offers direct access to obesity medication
HQ team January 6, 2024: Eli Lilly, the pharmaceutical company will now be selling its weightless drug directly to the consumer via its.
Drugs
Health
Medical
Novel long-acting GLP-1 agonist offers hope for type 2 diabetics
HQ Team November 4, 2023: Scientists at the University of Tabriz, Iran, have done pioneering work on a long-acting GLP-1 agonist that holds.
Drugs
Health
Pharma
Novo Nordisk’s weight-loss drug Wegovy enters the UK market
HQ Team September 4, 2023: Novo Nordisk, a Danish drugmaker, announced its weight-loss medicine, Wegovy, will be available in the UK in a.
Drugs
Health
Medical
Oral semaglutide reduces HbA1c, weight in Type 2 diabetics, study reveals
HQ Team June 8, 2023: A new study analyzing the PIONEER (Peptide Innovation for Early Diabetes Treatment) clinical trials data has revealed the.